Battle for Mosul sparks Iraq-Turkey rivalry

October 25, 2016

Oct 25: A dispute between Iraq and Turkey has emerged as a dramatic geopolitical sideshow to the complicated military campaign to retake Mosul, Iraq's second-largest city, from Islamic State (IS).

mosulPresident Recep Tayyip Erdogan of Turkey has insisted on a role in the battle for Mosul, trying to ramp up an involvement in Iraq that has already alarmed the Iraqi government.

“We have a historical responsibility in the region,” Erdogan said in a recent speech, drawing on his country's history of empire and defeat, from Ottoman rule of the Middle East to its loss in World War I. “If we want to be both at the table and in the field, there is a reason.”

In response, the normally mild-mannered Iraqi Prime Minister Haider al-Abadi, warned last week of a military confrontation between Turkey and Iraq. If Turkish forces intervene in Mosul, he said, they will not “be in a picnic.” “We are ready for them,” al-Abadi said. “This is not a threat or a warning. This is about Iraqi dignity.”

The rift between Turkey and Iraq is no mere diplomatic row; it is a stark example of the complete breakdown in sovereignty of not just Iraq but Syria as well. IS has erased the borders between the two countries, while Turkey has stationed troops in both countries without the permission of either government.

Turkey has angered the Iraqi government by keeping a unit of troops at a base in Bashiqa, an area of northern Iraq near Mosul and surrounded by IS territory. For more than a year, the Turks have also been training Kurdish peshmerga forces and Sunni Arab fighters in Iraq, including a militia led by a former governor of Mosul, Atheel al-Nujaifi.

The Turkish military deployment, even just to train local forces, has been bitterly opposed by the Iraqi government, and al-Abadi has demanded that the troops leave.

Now that the battle for Mosul has started, Erdogan has given a number of incendiary speeches in which he has seemed to suggest that he is itching for the Turkish military to become directly involved in the fighting.

The battle for Mosul began last week with a push by Kurdish and Iraqi forces, backed by US advisers and US airstrikes, to take back dozens of villages outside the city. For the US, Turkey, a Nato ally, has again proven itself a difficult partner in the fight against IS.

As it has in Syria, where Turkey has opposed, and sometimes bombed, Syrian Kurdish allies that are working with the US to fight the IS, Turkey has undermined US goals in Iraq by insisting on playing a role in the fight for Mosul.

For almost a year, US diplomats have sought to contain the crisis. They have encouraged the Turks to respect Iraq's sovereignty and aid the fight against the IS by carrying out activities under the umbrella of the US-led coalition.

But Turkey has kept its troops in Bashiqa, a deployment the Iraqi government says it never approved. According to a US State Department official, Turkey has about 600 to 800 troops at Bashiqa, equipped with tanks and artillery, and has sometimes fired on IS positions from there. Turkish troops did so on Sunday in support of Kurdish peshmerga fighters, officials said.

Zalmay Khalilzad, a former US ambassador to Afghanistan and Iraq, warned in a recent article in The National Interest that Turkey and Iraq may be heading for war. He wrote that there was a “danger of a war within a war that could damage the prospects for retaking and stabilising Mosul.”

Those fears seem extreme, if only because the Iraqis have their hands full with the IS. But defusing the tension has become another challenge for US diplomats.

The United States is trying to broker a compromise in which the Turks would not directly participate in the Mosul offensive but stick to training and perhaps medical and humanitarian support. In a visit to Turkey in recent days, US Defence Secretary Ash Carter said there was an agreement “in principle” between Turkey and Iraq, which the Iraqi government immediately denied. Iraq appears to want a commitment from the Turks that they will leave after Mosul is retaken.

Carter said the US is trying to balance “our respect for the sovereignty of Iraq” and “our respect also for Turkey's historic role in the region.”

Turkey has a number of strategic reasons for maintaining a military presence in northern Iraq. It wants a bulwark against the Kurdistan Workers' Party, or PKK, which is waging an insurgency in southeast Turkey and keeps bases in the mountains of northern Iraq. The PKK fought in the battle for Sinjar, in northern Iraq, last year.

Ottoman glory

Turkey, a Sunni power, also says it wants to protect ethnic Turkmen and Sunni Arabs in northern Iraq and counter the presence of Shiite Iran, which is dominant in Iraq and controls several well-equipped militias. More broadly, and in keeping with Erdogan's vision of reclaiming Ottoman glory, Turkey wants to project influence around the region, in Iraq but also in Syria, where in August the Turkish military intervened to push IS out of the city of Jarabulus.

At times, Erdogan has seized on the issue of Mosul to highlight, for his own public, century-old grievances that linger from the end of World War I, when Western powers divided the former Ottoman lands of the Middle East. “We did not voluntarily accept the borders of our country,” he said. He has also referred to a manifesto from the last Ottoman parliament, as the empire crumbled, claiming Mosul as part of Turkey. “Our most important task is to teach this to a new generation,” he said recently.

Mensur Akgun, director of the Global Political Trends Centre in Turkey, said that for Turks, “there is also an emotional side to the issue.” Referring to Mosul, Akgun said: “A century ago, that place was Turkey. A big geography was Turkey. It is committed in the memories that British and French imperialism was responsible.”

Erdogan has said he is worried about the presence in Iraq of Iranian-backed militias, which have been accused of abuses against Sunni civilians. At the same time, Turkey's presence has inflamed sectarian passions within Iraq.

In the run-up to the Mosul battle, the US worked closely with Iraqis to put together a force that included the Iraqi army, Kurdish forces and Sunni tribal fighters but not Shiite militias. But because of Turkey's insistence on playing a role, Shiite militia leaders now say they, too, might join the battle.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

Paris, Jun 29: More than half a million people have been killed by the novel coronavirus, nearly two thirds of them in the United States and Europe, according to an news agency tally at 2200 GMT Sunday based on official sources.

The official death count for the disease now stands at 500,390 deaths from 10,099,576 cases recorded worldwide. The United States has suffered the highest death count (125,747), followed by Brazil (57,622) and the United Kingdom (43,550).

The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.

Many countries are testing only the most serious cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 6,2020

Aboard Air Force One, Jan 6: US President Donald Trump threatened sanctions against Baghdad on Sunday after Iraq's parliament called on US troops to leave the country, and the president said if troops did leave, Baghdad would have to pay Washington for the cost of the air base there.

"We have a very extraordinarily expensive air base that's there. It cost billions of dollars to build, long before my time. We're not leaving unless they pay us back for it," Trump told reporters on Air Force One.

Trump said that if Iraq asked US forces to leave and it was not done on a friendly basis, "we will charge them sanctions like they've never seen before ever. It'll make Iranian sanctions look somewhat tame."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.